Alan Leviton1, Elizabeth N Allred2, Raina N Fichorova3, Karl C K Kuban4, T Michael O'Shea5, Olaf Dammann6. 1. Neuroepidemiology Unit, Department of Neurology, Boston Children's Hospital, Harvard University, Boston, MA 02115, United States. Electronic address: alan.leviton@childrens.harvard.edu. 2. Neuroepidemiology Unit, Department of Neurology, Boston Children's Hospital, Harvard University, Boston, MA 02115, United States. 3. Laboratory of Genital Tract Biology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, MA 02115, United States. 4. Division of Neurology, Department of Pediatrics, Boston Medical Center and Boston University, Boston, MA 02118, United States. 5. Department of Pediatrics, Wake Forest University, Winston-Salem, NC 27157, United States. 6. Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA 02111, United States; Perinatal Neuropidemiology Unit, Hannover Medical School, 30625 Hannover, Germany.
Abstract
BACKGROUND: Systemic inflammation during the first two postnatal weeks in extremely preterm newborns (<28weeks gestation) has been associated with an increased risk of neurodevelopmental dysfunctions. Little is known, however, about the relationship between systemic inflammation during the third and fourth postnatal weeks and subsequent development. METHODS: We measured the concentrations of 16 inflammation-related proteins in blood spots collected on postnatal days 21 (N=749) and 28 (N=697) from infants born before the 28th week of gestation and assessed at age 2years. We then sought the developmental correlates of top quartile concentrations for gestational age and day the specimen was collected. Odds ratios and 95% confidence intervals were calculated from regular or multinomial logistic regression models (as appropriate). RESULTS: Top quartile concentrations of CRP, IL-1β, IL-6, IL-6R, TNF-R2, IL-8, ICAM-1, and TSH on both days 21 and 28 were associated with ventriculomegaly (when in the NICU) and microcephaly at age 2years. Top quartile concentrations of CRP, SAA, IL-6, TNF-R2, IL-8, and ICAM-1 were associated with mental development index (MDI) of the Bayley-II<55, while top quartile concentrations of CRP, TNF-α (inversely), IL-8, and ICAM-1 were associated with psychomotor development index (PDI)<55 CONCLUSION: Extremely preterm newborns who had systemic inflammation during the third and fourth postnatal weeks were at increased risk of ventriculomegaly during the months after birth, and of microcephaly, and low Bayley Scale scores at 2years old.
BACKGROUND:Systemic inflammation during the first two postnatal weeks in extremely preterm newborns (<28weeks gestation) has been associated with an increased risk of neurodevelopmental dysfunctions. Little is known, however, about the relationship between systemic inflammation during the third and fourth postnatal weeks and subsequent development. METHODS: We measured the concentrations of 16 inflammation-related proteins in blood spots collected on postnatal days 21 (N=749) and 28 (N=697) from infants born before the 28th week of gestation and assessed at age 2years. We then sought the developmental correlates of top quartile concentrations for gestational age and day the specimen was collected. Odds ratios and 95% confidence intervals were calculated from regular or multinomial logistic regression models (as appropriate). RESULTS: Top quartile concentrations of CRP, IL-1β, IL-6, IL-6R, TNF-R2, IL-8, ICAM-1, and TSH on both days 21 and 28 were associated with ventriculomegaly (when in the NICU) and microcephaly at age 2years. Top quartile concentrations of CRP, SAA, IL-6, TNF-R2, IL-8, and ICAM-1 were associated with mental development index (MDI) of the Bayley-II<55, while top quartile concentrations of CRP, TNF-α (inversely), IL-8, and ICAM-1 were associated with psychomotor development index (PDI)<55 CONCLUSION: Extremely preterm newborns who had systemic inflammation during the third and fourth postnatal weeks were at increased risk of ventriculomegaly during the months after birth, and of microcephaly, and low Bayley Scale scores at 2years old.
Authors: Christian Gille; Stephan Dreschers; Anja Leiber; Florian Lepiorz; Matthias Krusch; Julia Grosse-Opphoff; Bärbel Spring; Martin Haas; Michael Urschitz; Christian F Poets; Thorsten W Orlikowsky Journal: Pediatr Res Date: 2012-12-26 Impact factor: 3.756
Authors: Ingrid Hansen-Pupp; Anne-Li Hallin; Lena Hellström-Westas; Corrado Cilio; Ann-Cathrine Berg; Karin Stjernqvist; Vineta Fellman; David Ley Journal: Pediatr Res Date: 2008-08 Impact factor: 3.756
Authors: Karl C K Kuban; T Michael O'Shea; Elizabeth N Allred; Nigel Paneth; Deborah Hirtz; Raina N Fichorova; Alan Leviton Journal: J Child Neurol Date: 2014-03-18 Impact factor: 1.987
Authors: Elizabeth N Allred; Olaf Dammann; Raina N Fichorova; Stephen R Hooper; Scott J Hunter; Robert M Joseph; Karl Kuban; Alan Leviton; Thomas Michael O'Shea; Megan N Scott Journal: J Neuroimmune Pharmacol Date: 2017-04-12 Impact factor: 4.147
Authors: Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann Journal: J Neuroimmune Pharmacol Date: 2018-09-06 Impact factor: 4.147
Authors: Elizabeth T Jensen; Jelske W van der Burg; Thomas M O'Shea; Robert M Joseph; Elizabeth N Allred; Tim Heeren; Alan Leviton; Karl C K Kuban Journal: J Pediatr Date: 2017-03-21 Impact factor: 4.406
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann Journal: Eur J Paediatr Neurol Date: 2018-01-31 Impact factor: 3.140
Authors: Alan Leviton; Stephen R Hooper; Scott J Hunter; Megan N Scott; Elizabeth N Allred; Robert M Joseph; T Michael O'Shea; Karl Kuban Journal: Pediatr Neurol Date: 2017-12-21 Impact factor: 3.372
Authors: H Reeve Bright; Kikelomo Babata; Elizabeth N Allred; Carmina Erdei; Karl C K Kuban; Robert M Joseph; T Michael O'Shea; Alan Leviton; Olaf Dammann Journal: J Pediatr Date: 2017-05-16 Impact factor: 4.406
Authors: Xiaodi Chen; Dawei Song; Sakura Nakada; Joseph Qiu; Karin Iwamoto; Ray H Chen; Yow-Pin Lim; William J Jusko; Barbara S Stonestreet Journal: Curr Pharm Des Date: 2020 Impact factor: 3.116